Posted innews Oncology Public Health
Evaluating the Impact of Multicancer Early-Detection Blood Tests on Late-Stage Cancer Diagnosis: Insights from a Large Randomized Trial
A large randomized trial assessing whether adding a blood-based multicancer early-detection test to usual care reduces late-stage cancer diagnoses found no significant difference in stage III or IV cancers but observed a trend toward fewer stage IV cancers after three screening rounds.